Harrys A. Torres, MD, FACP, FIDSA is an Associate Professor of Medicine in the Department of Infectious Diseases, Infection Control and Employee Health at the University of Texas M. D. Anderson Cancer Center in Houston, Texas. He is board certified in internal medicine, and in infectious disease, with additional accreditations on HIV/AIDS and Tropical Medicine and Hygiene. He is also founder and director of the Hepatitis C Virus (HCV) Clinic. The first established clinic in the United States devoted to managing HCV infection in cancer patients.
Dr. Torres is a member of numerous national committees for professional societies such as the Infectious Diseases Society of America, and the American Society for Blood and Marrow Transplantation. Dr. Torres is the principal investigator for multiple research grants. His research interest is to facilitate translational research in the prevention, detection and treatment of HCV and HIV in patients with cancer. He is also interested in the study of antiviral drug resistance in chronic HCV infection.
He is co-author of more than 80 articles published in peer-reviewed journals, including Journal of the National Cancer Institute, Clinical Infectious Diseases, Journal of Hepatology, Blood, and Nature Reviews Clinical Oncology. His publications are on infectious in cancer and hematopoietic cell transplant recipients with a focus on HCV and HIV. He has presented more than 90 abstracts in international meetings, and written 6 book chapters. His work on HCV has been awarded multiple times by the American Society of Clinical Oncology among others.
Dr. Torres has lectured widely nationally and internationally on infectious diseases, HCV and HIV/AIDS in cancer patients.